Drug intelligence / Profile preview

Orutexer Oral Ointment

Development stage
Unknown
Lead developer
Bee Brand Medico Dental
Modality
Small Molecules
Administration
Topical
01

Overview

Orutexer Oral Ointment (オルテクサー口腔用軟膏) is a topical corticosteroid formulation containing triamcinolone acetonide (0.1%) as its active ingredient. Developed by Bee Brand Medico Dental for prescription use and Fukuchi Pharmaceutical for over-the-counter (OTC) use, it is specifically designed to treat oral mucosal lesions. The ointment utilizes a specialized adhesive base (containing carboxyvinyl polymer) that adheres firmly to the wet oral mucosa, forming a protective gel barrier that resists being washed away by saliva. Triamcinolone acetonide exerts potent anti-inflammatory, anti-allergic, and immunosuppressive effects by binding to and activating the glucocorticoid receptor, thereby reducing pain and promoting healing. It is primarily indicated for chronic desquamative gingivitis, refractory stomatitis (canker sores/aphthous ulcers), and glossitis accompanied by erosion or ulceration.

Brand names
OrutexerOrutexer Oral OintmentOrutexer Oral Ointment 0.1%オルテクサーオルテクサー口腔用軟膏オルテクサー口腔用軟膏0.1%
Other names
triamcinolone acetonide oral ointmentトリアムシノロンアセトニド口腔軟膏トリアムシノロンアセトニド軟膏
02

Targets

GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on Orutexer Oral Ointment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orutexer Oral Ointment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call